Feb 10, 2016

CBS News investigation: Liquid biopsy giving false sense of security about cancer risk?

Posted by in categories: biotech/medical, security

Not good — CancerIntercept Detect and Monitor test is not providing accurate information in some results. The cancerIntercept test whole concept was to detect a growing tumor in the body, before the patient may notice symptoms — acting like a cancer stethoscope for detecting and monitoring cancer.

Pathway Genomics claims its liquid biopsy can detect cancer before patient shows symptoms — but expert says that promise is “years away”.

Read more

Comments are closed.